Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
01/06/2004 | US6673817 Anticoagulants |
01/06/2004 | US6673807 Administering compound possessing inhibitory activity on production of nitric oxide and tricyclic macrolide or salt, solvate or hydrate thereof to increase graft survival time in transplantation subject |
01/06/2004 | US6673803 Quinazoline derivatives and pharmaceutical compositions containing them |
01/06/2004 | US6673797 Cyclooxygenase-2 inhibitors; treating inflammatory disease induced by cyclooxygenase-2 |
01/06/2004 | US6673790 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
01/06/2004 | US6673787 Pyrimidinesulfonamide containing indole compounds used as antiangiogenic and antitumor agents |
01/06/2004 | CA2285891C Triazole antifungal agents |
01/02/2004 | EP1375486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
01/02/2004 | EP1375482A1 Benzamidine derivative |
01/02/2004 | EP1373271A1 Indole derivatives having an inhibitory effect on protein kinases |
01/02/2004 | EP1373259A1 Pyridazinone aldose reductase inhibitors |
01/02/2004 | EP1373257A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
01/02/2004 | EP1373256A1 Ccr5 antagonists useful for treating aids |
01/02/2004 | EP1373255A1 Process for the preparation of imidazole compounds |
01/02/2004 | EP1373254A1 New process |
01/02/2004 | EP1373253A1 Inhibitors of cyclin dependent kinases as anti-cancer agent |
01/02/2004 | EP1373224A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
01/02/2004 | EP1373223A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
01/02/2004 | EP1373222A2 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
01/02/2004 | EP1373221A2 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
01/02/2004 | EP1373219A1 Thiohydantoins and use thereof for treating diabetes |
01/02/2004 | EP1373218A1 Imidazolyl derivatives useful as histamine h3 receptor ligands |
01/02/2004 | EP1373217A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
01/02/2004 | EP1373204A2 Heterocyclic compounds |
01/02/2004 | EP1373203A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
01/02/2004 | EP1373194A1 BENZAMIDE INHIBITORS OF FACTOR Xa |
01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
01/02/2004 | EP1372692A2 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor |
01/02/2004 | EP1372657A2 A method of treating proliferative diseases using eg5 inhibitors |
01/02/2004 | EP0836595B1 Triazoline and isoxazoline bis-oxime derivatives and their use as pesticides |
01/01/2004 | US20040002608 Central nervous system disorders |
01/01/2004 | US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device |
01/01/2004 | US20040002535 Methods of treating hormone-related conditions using thio-oxindole derivatives |
01/01/2004 | US20040002534 Stem cell factor; signal transduction passageways; anticancer agents |
01/01/2004 | US20040002531 Imidazolyl derivatives |
01/01/2004 | US20040002527 Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
01/01/2004 | US20040002525 Obesity; osteoporosis |
01/01/2004 | US20040002524 Cardiovascular disorders; osteoporosis; central nervous system disorders |
01/01/2004 | US20040002508 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
01/01/2004 | US20040002495 Lactam glycogen phosphorylase inhibitors and method of use |
01/01/2004 | US20040002487 Bone disorders; osteoporosis; oral diseases; antiarthritic agents |
01/01/2004 | US20040002485 Enzyme inhibitors; viricides |
01/01/2004 | US20040002424 2-Amino-4-bicyclylamino-6H-1,3,5-triazines, processes for their preparation and their use as herbicides and plant growth regulators |
12/31/2003 | WO2004000833A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
12/31/2003 | WO2004000832A1 1-[(indol-3-yl)carbonyl] piperazine derivatives |
12/31/2003 | WO2004000819A1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
12/31/2003 | WO2004000817A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
12/31/2003 | WO2004000814A1 8-(biaryl) quinoline pde4 inhibitors |
12/31/2003 | WO2004000804A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
12/31/2003 | WO2004000227A2 Use of thio-oxindole derivatives in treatment of skin disorders |
12/31/2003 | WO2004000225A2 Use of thio-oxindole derivatives in treatment of hormone-related conditions |
12/31/2003 | WO2004000210A2 Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
12/31/2003 | WO2004000204A2 Labelled somatostatin analogs backbone cyclized through metal complexation |
12/31/2003 | WO2003060475A3 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues |
12/31/2003 | CN1132817C Process for preparation of heteroarylcarboxamides |
12/31/2003 | CN1132814C 含有磺酰胺的吲哚化合物 Sulfonamide-containing indole compound |
12/31/2003 | CA2490109A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
12/31/2003 | CA2490043A1 8-(biaryl) quinoline pde4 inhibitors |
12/31/2003 | CA2489813A1 Use of thio-oxindole derivatives in treatment of hormone-related conditions |
12/31/2003 | CA2489810A1 Use of thio-oxindole derivatives in treatment of skin disorders |
12/31/2003 | CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists |
12/31/2003 | CA2445515A1 Transcription factor modulating compounds and methods of use thereof |
12/30/2003 | US6670473 Inhibitors of nitric oxide synthase (nos) |
12/30/2003 | US6670383 Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity |
12/30/2003 | US6670362 Pyridazine endothelin antagonists |
12/30/2003 | CA2052884C Angiotensin 11 antagonists in the treatment of hyperuricemia |
12/29/2003 | CA2433983A1 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
12/25/2003 | WO2003105853A1 1-aryl-4-substituted piperazines derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
12/25/2003 | WO2003105846A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
12/25/2003 | US20030236420 Pharmaceuticals |
12/25/2003 | US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS |
12/25/2003 | US20030236294 Anticancer agents |
12/25/2003 | US20030236277 Viricides; immunomoderators |
12/25/2003 | US20030236267 Benzimidazole derivatives |
12/25/2003 | US20030236262 Dietetics; antidiabetic agents; sexual disorders |
12/25/2003 | US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents |
12/25/2003 | US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
12/25/2003 | US20030236251 Hepatitis virus viricides |
12/25/2003 | US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins |
12/25/2003 | US20030236248 Kappa agonist compounds and pharmaceutical formulations thereof |
12/25/2003 | US20030236198 For treatment of infections by drug resistant bacteria |
12/24/2003 | WO2003106628A2 Benzodiazepine inhibitors of mitochondial f>10< atp hydrolase and methods of inhibiting f>10< atp hydrolase |
12/24/2003 | WO2003106452A2 Antagonists of melanin concentrating hormone receptor |
12/24/2003 | WO2003106435A1 Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof |
12/24/2003 | WO2003106431A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
12/24/2003 | WO2003106430A1 Benzimidazole inhibitors of poly(adp-ribosyl) polymerase |
12/24/2003 | WO2003106416A2 Chemical process |
12/24/2003 | WO2003105855A1 Mitotic kinesin inhibitors |
12/24/2003 | WO2003105854A2 Substituted dihydropyrimidines, dihydropyrimidones and dihydropyrimidinethiones as calcium channel blockers |
12/24/2003 | WO2003105847A1 Ophthalmic compositions for treating ocular hypertension |
12/24/2003 | WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
12/24/2003 | WO2003061653A9 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases |
12/24/2003 | WO2002028829A3 Peptide deformylase inhibitors |
12/24/2003 | CN1131860C 依来曲普坦氢溴酸盐一水合物 According to eletriptan hydrobromide monohydrate |
12/24/2003 | CA2489648A1 Chemical process |
12/24/2003 | CA2489447A1 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
12/24/2003 | CA2488802A1 Ophthalmic compositions for treating ocular hypertension |
12/23/2003 | US6667335 NMDA (N-methyl-D-aspartate)-receptor subtype selective blockers |
12/23/2003 | US6667332 Benzisoxazolyl-pyrazole derivatives formed by salt formation with maleic acid and hydrochloric acid and cyclization with acetohydroxamic acid |
12/23/2003 | US6667330 Cytoprotective; neuroinflammation and neurodegenerative disorders; oxidative stress related conditions |